Survival among Women with Borderline Ovarian Tumors and Ovarian Carcinoma: A Population-Based Analysis

Cancer

Volumn 100, Issue 5, 2004, Pages 1045-1052

  Sherman, Mark E ^a   Mink, Pamela J ^b   Curtis, Rochelle ^a   Cote, Timothy R ^c   Brooks, Sandra ^d   Hartge, Patricia ^a   Devesa, Susan ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b EXPONENT INC   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Borderline; Low malignant potential; Mucinous; Neoplasia; Ovary; Serous; Survival

Indexed keywords

ADULT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; INTESTINE CANCER; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; OVARY CARCINOMA; OVARY TUMOR; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; SECOND CANCER; SURVIVAL RATE; TUMOR LOCALIZATION;

ADENOCARCINOMA, MUCINOUS; ADULT; AGE FACTORS; BIOPSY, NEEDLE; CARCINOMA; COHORT STUDIES; COMBINED MODALITY THERAPY; CYSTADENOCARCINOMA, SEROUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; OVARIECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL ANALYSIS;

EID: 1242291787     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20080     Document Type: Article

References (47)

1. Taylor HC Jr. Malignant and semimalignant tumors of the ovary. Surg Gynecol Obstet. 1929;48:702-712.
2. International Federation of Gynecology and Obstetrics. Classification and staging of malignant tumors in the female pelvis. Acta Obstet Gynecol Scan. 1971;50:1-7.
3. Serov SF, Scully RE, Sobin LH. Histologic typing of ovarian tumors. In: World Health Organization. International histological classification and staging of tumors: no. 9. Geneva: World Health Organization, 1973.
4. Mink P, Sherman ME, Devesa S. Incidence patterns of invasive and borderline ovarian tumors among white women and black women in the United States: results from the SEER program, 1978-1997. Cancer. 2002;95:2380-2389.
5. Lee KR, Scully RE. Mucinous tumors of the ovary. A clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with "pseudomyxoma peritonei." Am J Surg Pathol. 2000;24:1447-1464.
6. Rodriguez IM, Prat J. Mucinous tumors of the ovary. A clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas. Am J Surg Pathol. 2002;26:139-152.
7. Seidman JD, Kurman RJ. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol. 2000;31:539-557.
8. Silva EG, Kurman RJ, Russell P, Scully RE. Symposium: ovarian tumors of borderline malignancy. Int J Gynecol Pathol. 1996;15:281-302.
9. Zanetta G, Rota S, Chiari S, Bonazzi C, Bratina G, Mangioni C. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol. 2001;19:2658-2664.
10. Scully RE, Young RH, Clement PB. Surface epithelial-stromal tumors, serous tumors. In: Atlas of tumor pathology. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. Fascicle 23, third series. Bethesda: Armed Forces Institute of Pathology, 1998:51-79.
11. Scully RE, Young RH, Clement PB. Mucinous tumors and pseudomyxoma peritonei. In: Atlas of tumor pathology. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. Fascicle 23, third series. Bethesda: Armed Forces Institute of Pathology, 1998:81-105.
12. Seidman JD, Russell P, Kurman RJ. Surface epithelial tumors of the ovary. In: Kurman RJ, editor. Blaustein's pathology of the female genital tract. New York: Springer-Verlag, 2002:791-904.
13. Prat J, de Nictolis M. Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with invasion. Am J Surg Pathol. 2002;26:1111-1128.
14. Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol. 1996;20:1319-1330.
15. Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types. Am J Surg Pathol. 1996;20:1331-1345.
16. Eichorn JH, Bell DA, Young RH, Scully RE. Ovarian serous borderline tumors with micropapillary and cribriform patterns. A study of 40 cases and comparison with 44 cases without these patterns. Am J Surg Pathol. 1999;23:397-409.
17. Goldstein NS, Ceniza N. Ovarian micropapillary serous borderline tumors. Clinicopathologic features and outcome of seven surgically staged patients. Am J Clin Pathol. 2000;114:380-386.
18. Gershenson DM. Is micropapillary serous carcinoma for real? Cancer. 2002;95:677-680.
19. Kempson RL, Hendrickson MR. Ovarian serous borderline tumors: the citadel defended. Hum Pathol. 2000;31:525-526.
20. Prayson RA, Hart WR, Petras RE. Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors. Am J Surg Pathol. 1994;18:591-603.
21. Ronnett BM, Kurman RJ, Zahn CM, et al. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol. 1995;26:509-524.
22. Lee KR, Young RH. The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic findings in 50 cases. Am J Surg Pathol. 2003;27:281-292.
23. Seidman JD, Kurman RJ, Ronnett BM. Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol. 2003;27:985-993.
24. Trimble CL, Kosary C, Trimble EL. Long-term survival and patterns of care in women with ovarian tumors of low malignant potential. Gynecol Oncol. 2002;86:34-37.
25. Ries LA, Eisner MP, Kosary CL, et al., editors. SEER cancer statistics review, 1973-2000. Bethesda: National Cancer Institute, 2003.
26. Percy C, Van Holten V, Muir C, editors. International classification of diseases for oncology (2nd edition). Geneva: World Health Organization, 1990.
27. National Cancer Institute. SEER*Stat [software online]. Available from URL: http://seer.cancer.gov/seerstat [accessed 2003].
28. Massi D, Susini T, Savino L, Boddi V, Amunni G, Colafranceschi M. Epithelial ovarian tumors in the reproductive age group. Age is not an independent prognostic factor. Cancer. 1996;77:1131-1136.
29. Diebold J, Seemuller F, Lohrs U. K-ras mutations in ovarian and extraovarian lesions of serous tumors of borderline malignancy. Lab Invest. 2003;83:251-258.
30. Gu J, Roth LM, Younger C, et al. Molecular evidence for the independent origin of extra-ovarian papillary serous tumors of low malignant potential. J Natl Cancer Inst. 2001;93:1147-1152.
31. Lu KH, Bell DA, Welch WR, Berkowitz RS, Mok SC. Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors. Cancer Res. 1998;58:2328-2330.
32. Ortiz BH, Ailawadi M, Colitti C, et al. Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors. Cancer Res. 2001;61:7264-7267.
33. Sieben NL, Kolkman-Uljee SM, Flanagan AM, et al. Molecular genetic evidence for monoclonal origin of bilateral ovarian serous borderline tumors. Am J Pathol. 2003;162:1095-1101.
34. Harris R, Whittemore AS, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. Collaborative Ovarian Cancer Group. Am J Epidemiol. 1992;136:1204-1211.
35. Riman T, Dickman PW, Nilsson S, et al. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study. Gynecol Oncol. 2001;83:575-585.
36. Bell DA, Weinstock MA, Scully RE. Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis. Cancer. 1988;62:2212-2222.
37. Bell KA, Smith Sehdev AE, Kurman RJ. Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas. Am J Surg Pathol. 2001;25:419-432.
38. Silverberg SG. Histopathologic grading of ovarian carcinoma: a review and proposal. Int J Gynecol Pathol. 2000;19:7-15.
39. Vergote I, De Brabanter J, Fyles A, et al. Prognostic importance of degree of differentiation and cyst rupture in Stage I invasive epithelial ovarian carcinoma. Lancet. 2001;357:176-182.
40. Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 2002;359:572-577.
41. Schilder JM, Thompson AM, DePriest PD, et al. Outcome of reproductive age women with Stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol. 2002;87:1-7.
42. Marchbanks PA, Wilson H, Bastos E, Cramer DW, Schildkraut JM, Peterson HB. Cigarette smoking and epithelial ovarian cancer by histologic type. Obstet Gynecol. 2000;95:255-260.
43. Purdie DM, Siskind V, Bain CJ, Webb PM, Green AC. Reproduction-related risk factors for mucinous and non-mucinous epithelial ovarian cancer. Am J Epidemiol. 2001;153:860-864.
44. Risch HA, Marrett LD, Jain M, Howe GR. Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. Am J Epidemiol. 1996;144:363-372.
45. Schiffman MH, Hartge P, Hoover RN, McGowan L, Lesher L, Norris HJ. Epithelial ovarian cancer. Gynecol Oncol. 1989;33:129-132.
46. Green A, Purdie D, Bain C, Siskind V, Webb PM. Cigarette smoking and risk of epithelial ovarian cancer (Australia). Cancer Causes Control. 2001;12:713-719.
47. Modungo F, Ness RB, Cottreau CM. Cigarette smoking and the risk of mucinous and nonmucinous epithelial ovarian cancer. Epidemiology. 2002;13:467-471.